Table 3.
PICU Survival for Patients Not Treated with Intrapulmonary FVIIa.
| Variable | Total (n=18) | Survived ICU (n=7) | Died ICU (n=11) |
P Value |
|---|---|---|---|---|
| Age (years) | 0.196 | |||
| N | 18 | 7 | 11 | . |
| Mean (SD) | 10.4 (6.3) | 12.9 (6.1) | 8.9 (6.1) | . |
| Median (Range) | 11.5 (0.8~20.0) | 13.0 (1.0~20.0 | 10.0 (0.8~19.0 | . |
| Gender | 0.627 | |||
| Female | 12 (66.7%) | 4 (57.1%) | 8 (72.7%) | . |
| Male | 6 (33.3%) | 3 (42.9%) | 3 (27.3%) | . |
| Primary Diagnosis | 0.137 | |||
| Brain tumor | 1 (5.6%) | 1 (14.3%) | . | |
| Non-malignant Hematologic disorder | 1 (5.6%) | 1 (9.1%) | . | |
| Leukemia | 14 (77.8%) | 4 (57.1%) | 10 (90.9%) | . |
| Primary HLH | 1 (5.6%) | 1 (14.3%) | . | |
| Solid tumor | 1 (5.6%) | 1 (14.3%) | . | |
| Post HCT | 0.881 | |||
| No | 3 (16.7%) | 1 (14.3%) | 2 (18.2%) | . |
| Autologous | 1 (5.6%) | 1 (14.3%) | . | |
| MUD | 5 (27.8%) | 2 (28.6%) | 3 (27.3%) | . |
| Haploidentical | 9 (50.0%) | 3 (42.9%) | 6 (54.5%) | . |
| Diagnosis Pulmonary Hemorrhage | 1.000 | |||
| BAL | 11 (61.1%) | 4 (57.1%) | 7 (63.6%) | . |
| Clinical | 7 (38.9%) | 3 (42.9%) | 4 (36.4%) | . |
| OSI, pre | 1.000 | |||
| N | 12 | 5 | 7 | . |
| Mean (SD) | 18.2 (15.8) | 17.4 (13.4) | 18.7 (18.3) | . |
| Median (Range) | 11.4 (4.5~58.8) | 11.5 (4.5~38.8) | 11.3 (5.6~58.8) | . |
| OI, pre | NA | |||
| N | 4 | 1 | 3 | |
| Mean (SD) | 23.3 (13.8) | 2.6 (NA) | 30.2 (1.6) | |
| Median (Range) | 29.25 (2.6, 32.0) | 29.5 (29.0, 32.0) | ||
| PICU LOS, days | 0.093 | |||
| N | 18 | 7 | 11 | . |
| Mean (SD) | 26.9 (26.4) | 15.6 (11.4) | 34.2 (31.0) | . |
| Median (Range) | 18.5 (1.0~93.0) | 11.0 (3.0~36.0) | 23.0 (1.0~93.0) | . |
| Hospital LOS, days | 0.348 | |||
| N | 18 | 7 | 11 | . |
| Mean (SD) | 46.6 (31.6) | 37.6 (30.2) | 52.4 (32.5) | . |
| Median (Range) | 34.5 (3.0~109.0) | 29.0 (3.0~99.0) | 46.0 (4.0~109.0) | . |
| Vent free days | 0.004 | |||
| N | 18 | 7 | 11 | . |
| Mean (SD) | 6.1 (9.6) | 15.6 (9.3) | 0.0 (0.0) | . |
| Median (Range) | 0.0(0.0~25.0) | 19.0(3.0~25.0 | 0.0(0.0~0.0) | . |
| PLT count | 0.770 | |||
| N | 18 | 7 | 11 | . |
| Mean (SD) | 64.3 (35.6) | 68.1 (52.2) | 61.8 (22.6) | . |
| Median (Range) | 64.5 (8~130) | 81 (8~130) | 62 (32~112) | . |
| PT | 0.295 | |||
| N | 18 | 7 | 11 | . |
| Mean (SD) | 17.4 (3.7) | 18.6 (4.0) | 16.7 (3.4) | . |
| Median (Range) | 16.5 (13.0~24.9) | 17.7 (14.3~24.9) | 15.5 (13.0~22.5) | . |
| PTT | 0.406 | |||
| N | 17 | 7 | 10 | . |
| Mean (SD) | 53.4 (26.2) | 44.7 (17.0) | 59.6 (30.5) | . |
| Median (Range) | 41.2 (25.1~101.0) | 41.1(27.9~76.0) | 46.1 (25.1~101.0) | . |
| INR | 0.365 | |||
| N | 18 | 7 | 11 | . |
| Mean (SD) | 1.5 (0.4) | 1.6 (0.5) | 1.5 (0.4) | . |
| Median (Range) | 1.4 (1.1~2.3) | 1.5 (1.2~2.3) | 1.3 (1.1~2.2) | . |
| Fibrinogen | 0.934 | |||
| N | 17 | 6 | 11 | . |
| Mean (SD) | 351.4 (182.3) | 346.2 (148.5) | 354.2 (205.2) | . |
| Median (Range) | 381 (67~646) | 388.5 (96~511) | 317 (67~646) | . |
ICU, intensive care unit; HCT, hematopoietic cell transplant; auto, autologous; haplo, haploidentical; MSD, matched sibling donor; MUD, matched unrelated donor; BAL, bronchoalveolar lavage; OSI, oxygenation saturation index; OI, oxygenation index; SD, standard deviation; LOS, length of stay; Vent, ventilator; PLT, platelet; PT, prothrombin time; PTT, partial thromboplastin time; INR, internationalized standard ratio.